HEADER HYDROLASE 19-JUN-13 4BTU TITLE FACTOR XA IN COMPLEX WITH THE DUAL THROMBIN-FXA INHIBITOR 57. COMPND MOL_ID: 1; COMPND 2 MOLECULE: COAGULATION FACTOR X LIGHT CHAIN; COMPND 3 CHAIN: A, E; COMPND 4 FRAGMENT: LIGHT CHAIN, RESIDUES 84-179; COMPND 5 SYNONYM: STUART FACTOR, STUART-PROWER FACTOR, FACTOR X LIGHT CHAIN; COMPND 6 EC: 3.4.21.6; COMPND 7 OTHER_DETAILS: DES-GLA DOMAIN; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: COAGULATION FACTOR X HEAVY CHAIN; COMPND 10 CHAIN: B, F; COMPND 11 FRAGMENT: HEAVY CHAIN, RESIDUES 235-488; COMPND 12 SYNONYM: STUART FACTOR, STUART-PROWER FACTOR, FACTOR X HEAVY CHAIN; COMPND 13 EC: 3.4.21.6 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 TISSUE: SERUM; SOURCE 6 MOL_ID: 2; SOURCE 7 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 8 ORGANISM_COMMON: HUMAN; SOURCE 9 ORGANISM_TAXID: 9606; SOURCE 10 TISSUE: SERUM KEYWDS HYDROLASE, SAR107375, FACTOR XA INHIBITOR, THROMBIN INHIBITOR, KEYWDS 2 CHLOROTHIOPHENE P1 FRAGMENT, S3 SUBSITE, MICROSOMES STABILITY, ORAL KEYWDS 3 ANTITHROMBOTIC, DUAL INHIBITOR, IV ANTITHROMBOTIC EXPDTA X-RAY DIFFRACTION AUTHOR J.MENEYROL,M.FOLLMANN,G.LASSALLE,V.WEHNER,G.BARRE,T.ROUSSEAUX, AUTHOR 2 J.M.ALTENBURGER,F.PETIT,Z.BOCSKEI,C.STEHLIN-GAON,H.SCHREUDER,N.ALET, AUTHOR 3 J.-P.HERAULT,L.MILLET,F.DOL,C.HASBRAND,P.SCHAEFFER,F.SADOUN, AUTHOR 4 S.KLIEBER,C.BRIOT,F.BONO,J.-M.HERBERT REVDAT 4 01-MAY-24 4BTU 1 REMARK LINK REVDAT 3 08-MAY-19 4BTU 1 REMARK REVDAT 2 15-JAN-14 4BTU 1 JRNL REVDAT 1 18-DEC-13 4BTU 0 JRNL AUTH J.MENEYROL,M.FOLLMANN,G.LASSALLE,V.WEHNER,G.BARRE, JRNL AUTH 2 T.ROUSSEAUX,J.ALTENBURGER,F.PETIT,Z.BOCSKEI,H.SCHREUDER, JRNL AUTH 3 N.ALET,J.HERAULT,L.MILLET,F.DOL,P.FLORIAN,P.SCHAEFFER, JRNL AUTH 4 F.SADOUN,S.KLIEBER,C.BRIOT,F.BONO,J.HERBERT JRNL TITL 5-CHLOROTHIOPHENE-2-CARBOXYLIC ACID JRNL TITL 2 [(S)-2-[2-METHYL-3-(2-OXOPYRROLIDIN-1-YL) JRNL TITL 3 BENZENESULFONYLAMINO]-3-(4-METHYLPIPERAZIN-1-YL) JRNL TITL 4 -3-OXOPROPYL]AMIDE (SAR107375), A SELECTIVE AND POTENT JRNL TITL 5 ORALLY ACTIVE DUAL THROMBIN AND FACTOR XA INHIBITOR. JRNL REF J.MED.CHEM. V. 56 9441 2013 JRNL REFN ISSN 0022-2623 JRNL PMID 24175584 JRNL DOI 10.1021/JM4005835 REMARK 2 REMARK 2 RESOLUTION. 2.37 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.7.0029 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.37 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.51 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 23315 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.173 REMARK 3 R VALUE (WORKING SET) : 0.169 REMARK 3 FREE R VALUE : 0.248 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.600 REMARK 3 FREE R VALUE TEST SET COUNT : 1117 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.37 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.43 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1763 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2430 REMARK 3 BIN FREE R VALUE SET COUNT : 79 REMARK 3 BIN FREE R VALUE : 0.3500 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4498 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 80 REMARK 3 SOLVENT ATOMS : 566 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 40.68 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.80000 REMARK 3 B22 (A**2) : -0.80000 REMARK 3 B33 (A**2) : 1.60000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.129 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.060 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.183 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.656 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.945 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.891 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4784 ; 0.005 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6479 ; 0.968 ; 1.983 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 572 ; 4.465 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 217 ;34.589 ;23.963 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 805 ;14.391 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 32 ;12.959 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 677 ; 0.056 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3646 ; 0.002 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TWIN DETAILS REMARK 3 NUMBER OF TWIN DOMAINS : 2 REMARK 3 TWIN DOMAIN : 1 REMARK 3 TWIN OPERATOR : H, K, L REMARK 3 TWIN FRACTION : 0.521 REMARK 3 TWIN DOMAIN : 2 REMARK 3 TWIN OPERATOR : K, H, -L REMARK 3 TWIN FRACTION : 0.479 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN USED IF PRESENT IN REMARK 3 THE INPUT. U VALUES REFINED INDIVIDUALLY REMARK 4 REMARK 4 4BTU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 19-JUN-13. REMARK 100 THE DEPOSITION ID IS D_1290057354. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-APR-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.87260 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24437 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.370 REMARK 200 RESOLUTION RANGE LOW (A) : 55.760 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 3.200 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.37 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.45 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : 0.41000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: IN-HOUSE FACTOR XA STRUCTURE REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.42 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN SOLUTION: 8 MG/ML REMARK 280 REMARK 280 DESGLA FACTOR XA, 5 MM MES (PH 6.0), 5 MM CACL2, 100 MM REMARK REMARK 280 280 BENZAMIDINE. RESERVOIR SOLUTION: 18-20% PEG600, 50 MM MES REMARK 280 REMARK 280 (PH 5.7). HANGING DROP SETUP., VAPOR DIFFUSION, REMARK 280 HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 115.42667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 57.71333 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1720 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13460 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -9.1 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1790 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13620 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -20.5 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 TYR A -41 REMARK 465 LYS A -40 REMARK 465 ASP A -39 REMARK 465 GLY A -38 REMARK 465 ASP A -37 REMARK 465 GLN A -36 REMARK 465 CYS A -35 REMARK 465 GLU A -34 REMARK 465 THR A -33 REMARK 465 SER A -32 REMARK 465 PRO A -31 REMARK 465 CYS A -30 REMARK 465 GLN A -29 REMARK 465 ASN A -28 REMARK 465 GLN A -27 REMARK 465 GLY A -26 REMARK 465 LYS A -25 REMARK 465 CYS A -24 REMARK 465 LYS A -23 REMARK 465 ASP A -22 REMARK 465 GLY A -21 REMARK 465 LEU A -20 REMARK 465 GLY A -19 REMARK 465 GLU A -18 REMARK 465 TYR A -17 REMARK 465 THR A -16 REMARK 465 CYS A -15 REMARK 465 THR A -14 REMARK 465 CYS A -13 REMARK 465 LEU A -12 REMARK 465 GLU A -11 REMARK 465 GLY A -10 REMARK 465 PHE A -9 REMARK 465 GLU A -8 REMARK 465 GLY A -7 REMARK 465 LYS A -6 REMARK 465 ASN A -5 REMARK 465 CYS A -4 REMARK 465 GLU A -3 REMARK 465 LEU A -2 REMARK 465 PHE A -1 REMARK 465 THR A 0 REMARK 465 GLY B 246 REMARK 465 LEU B 247 REMARK 465 PRO B 248 REMARK 465 LYS B 249 REMARK 465 ALA B 250 REMARK 465 LYS B 251 REMARK 465 SER B 252 REMARK 465 HIS B 253 REMARK 465 ALA B 254 REMARK 465 PRO B 255 REMARK 465 GLU B 256 REMARK 465 VAL B 257 REMARK 465 ILE B 258 REMARK 465 THR B 259 REMARK 465 SER B 260 REMARK 465 SER B 261 REMARK 465 PRO B 262 REMARK 465 LEU B 263 REMARK 465 LYS B 264 REMARK 465 TYR E -41 REMARK 465 LYS E -40 REMARK 465 ASP E -39 REMARK 465 GLY E -38 REMARK 465 ASP E -37 REMARK 465 GLN E -36 REMARK 465 CYS E -35 REMARK 465 GLU E -34 REMARK 465 THR E -33 REMARK 465 SER E -32 REMARK 465 PRO E -31 REMARK 465 CYS E -30 REMARK 465 GLN E -29 REMARK 465 ASN E -28 REMARK 465 GLN E -27 REMARK 465 GLY E -26 REMARK 465 LYS E -25 REMARK 465 CYS E -24 REMARK 465 LYS E -23 REMARK 465 ASP E -22 REMARK 465 GLY E -21 REMARK 465 LEU E -20 REMARK 465 GLY E -19 REMARK 465 GLU E -18 REMARK 465 TYR E -17 REMARK 465 THR E -16 REMARK 465 CYS E -15 REMARK 465 THR E -14 REMARK 465 CYS E -13 REMARK 465 LEU E -12 REMARK 465 GLU E -11 REMARK 465 GLY E -10 REMARK 465 PHE E -9 REMARK 465 GLU E -8 REMARK 465 GLY E -7 REMARK 465 LYS E -6 REMARK 465 ASN E -5 REMARK 465 CYS E -4 REMARK 465 GLU E -3 REMARK 465 LEU E -2 REMARK 465 PHE E -1 REMARK 465 THR E 0 REMARK 465 GLY F 246 REMARK 465 LEU F 247 REMARK 465 PRO F 248 REMARK 465 LYS F 249 REMARK 465 ALA F 250 REMARK 465 LYS F 251 REMARK 465 SER F 252 REMARK 465 HIS F 253 REMARK 465 ALA F 254 REMARK 465 PRO F 255 REMARK 465 GLU F 256 REMARK 465 VAL F 257 REMARK 465 ILE F 258 REMARK 465 THR F 259 REMARK 465 SER F 260 REMARK 465 SER F 261 REMARK 465 PRO F 262 REMARK 465 LEU F 263 REMARK 465 LYS F 264 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 51 CA C O CB CG CD NE REMARK 470 ARG A 51 CZ NH1 NH2 REMARK 470 ARG B 245 CA C O CB CG CD NE REMARK 470 ARG B 245 CZ NH1 NH2 REMARK 470 ARG E 51 CA C O CB CG CD NE REMARK 470 ARG E 51 CZ NH1 NH2 REMARK 470 ARG F 245 CA C O CB CG CD NE REMARK 470 ARG F 245 CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 1C -120.18 62.80 REMARK 500 GLN A 10 -110.18 -128.57 REMARK 500 GLN A 16 75.45 57.64 REMARK 500 ASN A 17 -61.09 50.80 REMARK 500 ASN B 35 -168.79 -72.22 REMARK 500 GLU B 37 42.62 -108.07 REMARK 500 ASN B 38 -11.79 64.58 REMARK 500 ASN B 92 3.74 -64.17 REMARK 500 ARG B 115 -165.64 -165.17 REMARK 500 ASN B 117 -9.61 78.49 REMARK 500 SER B 214 -71.34 -109.44 REMARK 500 GLU B 217 95.37 -68.46 REMARK 500 MET B 242 43.99 -83.51 REMARK 500 LYS B 243 -46.03 -130.29 REMARK 500 LEU E 1C -106.31 57.56 REMARK 500 ASN E 5 18.16 56.24 REMARK 500 GLN E 10 -108.09 -122.35 REMARK 500 ASN E 17 -73.87 66.78 REMARK 500 LYS E 34 -40.55 -135.46 REMARK 500 SER F 48 -161.05 -165.31 REMARK 500 ARG F 115 -155.89 -151.05 REMARK 500 GLN F 187 70.95 -68.96 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2020 DISTANCE = 6.43 ANGSTROMS REMARK 525 HOH A2024 DISTANCE = 5.82 ANGSTROMS REMARK 525 HOH A3082 DISTANCE = 8.81 ANGSTROMS REMARK 525 HOH A3083 DISTANCE = 9.19 ANGSTROMS REMARK 525 HOH A3084 DISTANCE = 8.11 ANGSTROMS REMARK 525 HOH A3085 DISTANCE = 8.16 ANGSTROMS REMARK 525 HOH A3086 DISTANCE = 7.14 ANGSTROMS REMARK 525 HOH A3087 DISTANCE = 7.61 ANGSTROMS REMARK 525 HOH A3088 DISTANCE = 7.26 ANGSTROMS REMARK 525 HOH A3089 DISTANCE = 7.13 ANGSTROMS REMARK 525 HOH A3090 DISTANCE = 6.45 ANGSTROMS REMARK 525 HOH A3091 DISTANCE = 7.25 ANGSTROMS REMARK 525 HOH A3092 DISTANCE = 9.60 ANGSTROMS REMARK 525 HOH A3093 DISTANCE = 6.30 ANGSTROMS REMARK 525 HOH B2211 DISTANCE = 6.54 ANGSTROMS REMARK 525 HOH B2212 DISTANCE = 7.87 ANGSTROMS REMARK 525 HOH B2218 DISTANCE = 8.58 ANGSTROMS REMARK 525 HOH B2219 DISTANCE = 7.73 ANGSTROMS REMARK 525 HOH E2018 DISTANCE = 5.96 ANGSTROMS REMARK 525 HOH E2019 DISTANCE = 6.65 ANGSTROMS REMARK 525 HOH E2063 DISTANCE = 9.65 ANGSTROMS REMARK 525 HOH E2064 DISTANCE = 7.97 ANGSTROMS REMARK 525 HOH F2011 DISTANCE = 7.80 ANGSTROMS REMARK 525 HOH F2032 DISTANCE = 6.02 ANGSTROMS REMARK 525 HOH F2054 DISTANCE = 6.88 ANGSTROMS REMARK 525 HOH F2185 DISTANCE = 6.07 ANGSTROMS REMARK 525 HOH F2190 DISTANCE = 6.48 ANGSTROMS REMARK 525 HOH F2191 DISTANCE = 5.84 ANGSTROMS REMARK 525 HOH F2192 DISTANCE = 8.12 ANGSTROMS REMARK 525 HOH F2201 DISTANCE = 7.34 ANGSTROMS REMARK 525 HOH F2202 DISTANCE = 7.20 ANGSTROMS REMARK 525 HOH F2205 DISTANCE = 8.00 ANGSTROMS REMARK 525 HOH F2208 DISTANCE = 8.33 ANGSTROMS REMARK 525 HOH F2215 DISTANCE = 7.08 ANGSTROMS REMARK 525 HOH F2216 DISTANCE = 8.34 ANGSTROMS REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA B1245 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP B 70 OD1 REMARK 620 2 ASN B 72 O 76.2 REMARK 620 3 GLN B 75 O 148.1 73.0 REMARK 620 N 1 2 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA F1245 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP F 70 OD1 REMARK 620 2 ASN F 72 O 79.0 REMARK 620 3 GLN F 75 O 125.9 75.2 REMARK 620 4 GLU F 80 OE2 71.6 148.3 112.9 REMARK 620 N 1 2 3 REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: DSSP REMARK 700 THE SHEETS PRESENTED AS "BB" IN EACH CHAIN ON SHEET RECORDS REMARK 700 BELOW IS ACTUALLY AN 6-STRANDED BARREL THIS IS REPRESENTED BY REMARK 700 A 7-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS REMARK 700 ARE IDENTICAL. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA B 1245 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA F 1245 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 6XS F 1246 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 6XS B 1246 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4BTI RELATED DB: PDB REMARK 900 FACTOR XA IN COMPLEX WITH THE DUAL THROMBIN-FXA INHIBITOR 58. REMARK 900 RELATED ID: 4BTT RELATED DB: PDB REMARK 900 FACTOR XA IN COMPLEX WITH THE DUAL THROMBIN-FXA INHIBITOR 31. REMARK 999 REMARK 999 SEQUENCE REMARK 999 GLA DOMAIN REMOVED WITH CHYMOTRYPSIN DBREF 4BTU A -41 51 UNP P00742 FA10_HUMAN 84 179 DBREF 4BTU B 16 264 UNP P00742 FA10_HUMAN 235 488 DBREF 4BTU E -41 51 UNP P00742 FA10_HUMAN 84 179 DBREF 4BTU F 16 264 UNP P00742 FA10_HUMAN 235 488 SEQRES 1 A 96 TYR LYS ASP GLY ASP GLN CYS GLU THR SER PRO CYS GLN SEQRES 2 A 96 ASN GLN GLY LYS CYS LYS ASP GLY LEU GLY GLU TYR THR SEQRES 3 A 96 CYS THR CYS LEU GLU GLY PHE GLU GLY LYS ASN CYS GLU SEQRES 4 A 96 LEU PHE THR ARG LYS LEU CYS SER LEU ASP ASN GLY ASP SEQRES 5 A 96 CYS ASP GLN PHE CYS HIS GLU GLU GLN ASN SER VAL VAL SEQRES 6 A 96 CYS SER CYS ALA ARG GLY TYR THR LEU ALA ASP ASN GLY SEQRES 7 A 96 LYS ALA CYS ILE PRO THR GLY PRO TYR PRO CYS GLY LYS SEQRES 8 A 96 GLN THR LEU GLU ARG SEQRES 1 B 254 ILE VAL GLY GLY GLN GLU CYS LYS ASP GLY GLU CYS PRO SEQRES 2 B 254 TRP GLN ALA LEU LEU ILE ASN GLU GLU ASN GLU GLY PHE SEQRES 3 B 254 CYS GLY GLY THR ILE LEU SER GLU PHE TYR ILE LEU THR SEQRES 4 B 254 ALA ALA HIS CYS LEU TYR GLN ALA LYS ARG PHE LYS VAL SEQRES 5 B 254 ARG VAL GLY ASP ARG ASN THR GLU GLN GLU GLU GLY GLY SEQRES 6 B 254 GLU ALA VAL HIS GLU VAL GLU VAL VAL ILE LYS HIS ASN SEQRES 7 B 254 ARG PHE THR LYS GLU THR TYR ASP PHE ASP ILE ALA VAL SEQRES 8 B 254 LEU ARG LEU LYS THR PRO ILE THR PHE ARG MET ASN VAL SEQRES 9 B 254 ALA PRO ALA CYS LEU PRO GLU ARG ASP TRP ALA GLU SER SEQRES 10 B 254 THR LEU MET THR GLN LYS THR GLY ILE VAL SER GLY PHE SEQRES 11 B 254 GLY ARG THR HIS GLU LYS GLY ARG GLN SER THR ARG LEU SEQRES 12 B 254 LYS MET LEU GLU VAL PRO TYR VAL ASP ARG ASN SER CYS SEQRES 13 B 254 LYS LEU SER SER SER PHE ILE ILE THR GLN ASN MET PHE SEQRES 14 B 254 CYS ALA GLY TYR ASP THR LYS GLN GLU ASP ALA CYS GLN SEQRES 15 B 254 GLY ASP SER GLY GLY PRO HIS VAL THR ARG PHE LYS ASP SEQRES 16 B 254 THR TYR PHE VAL THR GLY ILE VAL SER TRP GLY GLU GLY SEQRES 17 B 254 CYS ALA ARG LYS GLY LYS TYR GLY ILE TYR THR LYS VAL SEQRES 18 B 254 THR ALA PHE LEU LYS TRP ILE ASP ARG SER MET LYS THR SEQRES 19 B 254 ARG GLY LEU PRO LYS ALA LYS SER HIS ALA PRO GLU VAL SEQRES 20 B 254 ILE THR SER SER PRO LEU LYS SEQRES 1 E 96 TYR LYS ASP GLY ASP GLN CYS GLU THR SER PRO CYS GLN SEQRES 2 E 96 ASN GLN GLY LYS CYS LYS ASP GLY LEU GLY GLU TYR THR SEQRES 3 E 96 CYS THR CYS LEU GLU GLY PHE GLU GLY LYS ASN CYS GLU SEQRES 4 E 96 LEU PHE THR ARG LYS LEU CYS SER LEU ASP ASN GLY ASP SEQRES 5 E 96 CYS ASP GLN PHE CYS HIS GLU GLU GLN ASN SER VAL VAL SEQRES 6 E 96 CYS SER CYS ALA ARG GLY TYR THR LEU ALA ASP ASN GLY SEQRES 7 E 96 LYS ALA CYS ILE PRO THR GLY PRO TYR PRO CYS GLY LYS SEQRES 8 E 96 GLN THR LEU GLU ARG SEQRES 1 F 254 ILE VAL GLY GLY GLN GLU CYS LYS ASP GLY GLU CYS PRO SEQRES 2 F 254 TRP GLN ALA LEU LEU ILE ASN GLU GLU ASN GLU GLY PHE SEQRES 3 F 254 CYS GLY GLY THR ILE LEU SER GLU PHE TYR ILE LEU THR SEQRES 4 F 254 ALA ALA HIS CYS LEU TYR GLN ALA LYS ARG PHE LYS VAL SEQRES 5 F 254 ARG VAL GLY ASP ARG ASN THR GLU GLN GLU GLU GLY GLY SEQRES 6 F 254 GLU ALA VAL HIS GLU VAL GLU VAL VAL ILE LYS HIS ASN SEQRES 7 F 254 ARG PHE THR LYS GLU THR TYR ASP PHE ASP ILE ALA VAL SEQRES 8 F 254 LEU ARG LEU LYS THR PRO ILE THR PHE ARG MET ASN VAL SEQRES 9 F 254 ALA PRO ALA CYS LEU PRO GLU ARG ASP TRP ALA GLU SER SEQRES 10 F 254 THR LEU MET THR GLN LYS THR GLY ILE VAL SER GLY PHE SEQRES 11 F 254 GLY ARG THR HIS GLU LYS GLY ARG GLN SER THR ARG LEU SEQRES 12 F 254 LYS MET LEU GLU VAL PRO TYR VAL ASP ARG ASN SER CYS SEQRES 13 F 254 LYS LEU SER SER SER PHE ILE ILE THR GLN ASN MET PHE SEQRES 14 F 254 CYS ALA GLY TYR ASP THR LYS GLN GLU ASP ALA CYS GLN SEQRES 15 F 254 GLY ASP SER GLY GLY PRO HIS VAL THR ARG PHE LYS ASP SEQRES 16 F 254 THR TYR PHE VAL THR GLY ILE VAL SER TRP GLY GLU GLY SEQRES 17 F 254 CYS ALA ARG LYS GLY LYS TYR GLY ILE TYR THR LYS VAL SEQRES 18 F 254 THR ALA PHE LEU LYS TRP ILE ASP ARG SER MET LYS THR SEQRES 19 F 254 ARG GLY LEU PRO LYS ALA LYS SER HIS ALA PRO GLU VAL SEQRES 20 F 254 ILE THR SER SER PRO LEU LYS HET CA B1245 1 HET 6XS B1246 78 HET CA F1245 1 HET 6XS F1246 78 HETNAM CA CALCIUM ION HETNAM 6XS 5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID [(S)-2-[2-CHLORO- HETNAM 2 6XS 5-FLUORO-3-(2-OXO-PIPERIDIN-1-YL)- HETNAM 3 6XS BENZENESULFONYLAMINO]-3-(4-METHYL-PIPERAZIN-1-YL)-3- HETNAM 4 6XS OXO-PROPYL]-AMIDE FORMUL 5 CA 2(CA 2+) FORMUL 6 6XS 2(C24 H28 CL2 F N5 O5 S2) FORMUL 9 HOH *566(H2 O) HELIX 1 1 LYS A 1B LEU A 3 5 5 HELIX 2 2 LEU A 3 CYS A 8 5 6 HELIX 3 3 ALA B 55 GLN B 61 5 7 HELIX 4 4 GLU B 124A LEU B 131A 1 9 HELIX 5 5 ASP B 164 SER B 172 1 9 HELIX 6 6 PHE B 234 MET B 242 1 9 HELIX 7 7 LEU E 3 CYS E 8 5 6 HELIX 8 8 ALA F 55 GLN F 61 5 7 HELIX 9 9 GLU F 124A THR F 131 1 8 HELIX 10 10 ASP F 164 SER F 172 1 9 HELIX 11 11 PHE F 234 MET F 242 1 9 SHEET 1 AA 2 PHE A 11 GLU A 14 0 SHEET 2 AA 2 VAL A 19 SER A 22 -1 O VAL A 20 N HIS A 13 SHEET 1 AB 2 TYR A 27 LEU A 29 0 SHEET 2 AB 2 CYS A 36 PRO A 38 -1 O ILE A 37 N THR A 28 SHEET 1 BA 7 GLN B 20 GLU B 21 0 SHEET 2 BA 7 LYS B 156 PRO B 161 -1 O MET B 157 N GLN B 20 SHEET 3 BA 7 THR B 135 GLY B 140 -1 O GLY B 136 N VAL B 160 SHEET 4 BA 7 PRO B 198 PHE B 203 -1 O PRO B 198 N SER B 139 SHEET 5 BA 7 THR B 206 TRP B 215 -1 O THR B 206 N PHE B 203 SHEET 6 BA 7 GLY B 226 LYS B 230 -1 O ILE B 227 N TRP B 215 SHEET 7 BA 7 MET B 180 ALA B 183 -1 O PHE B 181 N TYR B 228 SHEET 1 BB 7 GLN B 30 ILE B 34 0 SHEET 2 BB 7 GLY B 40 ILE B 46 -1 N PHE B 41 O LEU B 33 SHEET 3 BB 7 TYR B 51 THR B 54 -1 O LEU B 53 N THR B 45 SHEET 4 BB 7 ALA B 104 LEU B 108 -1 O ALA B 104 N THR B 54 SHEET 5 BB 7 ALA B 81 LYS B 90 -1 N GLU B 86 O ARG B 107 SHEET 6 BB 7 LYS B 65 VAL B 68 -1 O VAL B 66 N HIS B 83 SHEET 7 BB 7 GLN B 30 ILE B 34 -1 O LEU B 32 N ARG B 67 SHEET 1 EA 2 PHE E 11 GLU E 14 0 SHEET 2 EA 2 VAL E 19 SER E 22 -1 O VAL E 20 N HIS E 13 SHEET 1 EB 2 TYR E 27 LEU E 29 0 SHEET 2 EB 2 CYS E 36 PRO E 38 -1 O ILE E 37 N THR E 28 SHEET 1 FA 7 GLN F 20 GLU F 21 0 SHEET 2 FA 7 LYS F 156 PRO F 161 -1 O MET F 157 N GLN F 20 SHEET 3 FA 7 THR F 135 GLY F 140 -1 O GLY F 136 N VAL F 160 SHEET 4 FA 7 PRO F 198 PHE F 203 -1 O PRO F 198 N SER F 139 SHEET 5 FA 7 THR F 206 GLY F 216 -1 O THR F 206 N PHE F 203 SHEET 6 FA 7 GLY F 226 LYS F 230 -1 O ILE F 227 N TRP F 215 SHEET 7 FA 7 MET F 180 ALA F 183 -1 O PHE F 181 N TYR F 228 SHEET 1 FB 7 ALA F 81 HIS F 83 0 SHEET 2 FB 7 LYS F 65 VAL F 68 -1 O VAL F 66 N HIS F 83 SHEET 3 FB 7 GLN F 30 ILE F 34 -1 O LEU F 32 N ARG F 67 SHEET 4 FB 7 GLY F 40 ILE F 46 -1 N PHE F 41 O LEU F 33 SHEET 5 FB 7 TYR F 51 THR F 54 -1 O LEU F 53 N THR F 45 SHEET 6 FB 7 ALA F 104 LEU F 108 -1 O ALA F 104 N THR F 54 SHEET 7 FB 7 VAL F 85 LYS F 90 -1 N GLU F 86 O ARG F 107 SSBOND 1 CYS A 1 CYS A 12 1555 1555 2.04 SSBOND 2 CYS A 8 CYS A 21 1555 1555 2.03 SSBOND 3 CYS A 23 CYS A 36 1555 1555 2.03 SSBOND 4 CYS A 44 CYS B 122 1555 1555 2.04 SSBOND 5 CYS B 22 CYS B 27 1555 1555 2.03 SSBOND 6 CYS B 42 CYS B 58 1555 1555 2.03 SSBOND 7 CYS B 168 CYS B 182 1555 1555 2.03 SSBOND 8 CYS B 191 CYS B 220 1555 1555 2.03 SSBOND 9 CYS E 1 CYS E 12 1555 1555 2.03 SSBOND 10 CYS E 8 CYS E 21 1555 1555 2.03 SSBOND 11 CYS E 23 CYS E 36 1555 1555 2.03 SSBOND 12 CYS E 44 CYS F 122 1555 1555 2.03 SSBOND 13 CYS F 22 CYS F 27 1555 1555 2.04 SSBOND 14 CYS F 42 CYS F 58 1555 1555 2.03 SSBOND 15 CYS F 168 CYS F 182 1555 1555 2.02 SSBOND 16 CYS F 191 CYS F 220 1555 1555 2.03 LINK OD1 ASP B 70 CA CA B1245 1555 1555 2.52 LINK O ASN B 72 CA CA B1245 1555 1555 2.36 LINK O GLN B 75 CA CA B1245 1555 1555 2.42 LINK OD1 ASP F 70 CA CA F1245 1555 1555 2.63 LINK O ASN F 72 CA CA F1245 1555 1555 1.93 LINK O GLN F 75 CA CA F1245 1555 1555 3.12 LINK OE2 GLU F 80 CA CA F1245 1555 1555 2.09 SITE 1 AC1 5 ASP B 70 ASN B 72 GLN B 75 GLU B 77 SITE 2 AC1 5 GLU B 80 SITE 1 AC2 5 ASP F 70 ASN F 72 GLN F 75 GLU F 77 SITE 2 AC2 5 GLU F 80 SITE 1 AC3 16 HIS F 57 GLN F 61 LYS F 96 GLU F 97 SITE 2 AC3 16 THR F 98 TYR F 99 ALA F 190 GLN F 192 SITE 3 AC3 16 VAL F 213 SER F 214 TRP F 215 GLY F 216 SITE 4 AC3 16 GLY F 219 ILE F 227 TYR F 228 HOH F2181 SITE 1 AC4 15 GLN B 61 GLU B 97 TYR B 99 ASP B 189 SITE 2 AC4 15 ALA B 190 CYS B 191 GLN B 192 TRP B 215 SITE 3 AC4 15 GLY B 216 GLY B 219 CYS B 220 GLY B 226 SITE 4 AC4 15 TYR B 228 HOH B2071 ASN F 92 CRYST1 55.760 55.760 173.140 90.00 90.00 120.00 P 32 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017934 0.010354 0.000000 0.00000 SCALE2 0.000000 0.020708 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005776 0.00000